Extending FDA-approved cancer drug indications requires high patient numbers, study finds Post author: Post published: September 29, 2023 Post category:uncategorized Number of patient participants needed for secondary approval of a new cancer drug. You Might Also Like Categorizing the risk factors for portal vein thrombosis in liver cirrhosis September 30, 2025 Study shows growing cancer treatment inequities between high and low-income countries November 24, 2024 Novel screening method boosts early diagnosis of leprosy April 6, 2026
Study shows growing cancer treatment inequities between high and low-income countries November 24, 2024